This course was last updated on
August 31, 2018
CME credit has expired.
Peter D. Friedmann, MD, MPH, FASAM, FACP, and Jonna I. Gaberman, MD, provide their insights into the myriad challenges faced by clinicians in managing patients with opioid use disorder. The faculty discuss tools and factors to consider in the identification and assessment of persons with opioid use disorder. Treatment principles, including the importance of patient collaboration, comprehensive treatment, and harm reduction, are described, that set the stage for detailed discussion of the roles, benefits, and limitations of medications approved for medication-assisted treatment. The faculty conclude by discussing the roles of primary care providers in the long-term management of patients with opioid use disorder.
Enter your information to begin.

Content Areas

  • Screening tools
  • Assessment, including DSM-V criteria
  • Treatment principles for opioid use disorder
  • Efficacy/Safety of approved medications
  • Roles of primary care providers


Peter D. Friedmann, MD
Baystate Health
Associate Dean for Research
University of Massachusetts Medical School - Baystate
Chief Research Officer, Baystate Health Professor of Medicine
University of Massachusetts Medical School-Baystate
Professor of Quantitative Health Sciences University of Massachusetts Medical School
Springfield, Massachusetts
Jonna Gaberman, MD
Assistant Professor of Medicine
Tufts University School of Medicine
Baystate Medical Center
Springfield, Massachusetts

Cme credit

Available Credit: 1.00 AMA PRA Category 1 Credit™.
Opens: August 31, 2018
Expires: August 30, 2019
Target Audience: Primary Care Physicians
Addiction Specialists
Nurse Practitioners
Physician Assistants
Other Healthcare Providers
This activity is supported by an independent educational grant from Alkermes.